Serotonin-1D hypothesis of obsessive-compulsive disorder: An update

Joseph Zohar, James L. Kennedy, Eric Hollander, Lorrin M. Koran

Research output: Contribution to journalReview article

48 Scopus citations

Abstract

Support for the serotonin-1D (5-HT1D) hypothesis of obsessive-compulsive disorder (OCD) and related conditions comes from a variety of sources. Some pharmacologic challenges with the 5-HT1D agonist sumatriptan, and case reports in which prolonged administration of 5-HT 1D agonists was associated with a therapeutic effect, suggest that 5-HT1D may play a role in obsessive-compulsive symptoms. Genetic studies have also found that polymorphism of the 5-HT1D gene may be preferentially transmitted to those patients with OCD. However, taking into account that OCD is a heterogeneous syndrome, the 5-HT1D hypothesis requires further investigation in order to disentangle the role of the 5-HT 1D receptor in this common and often severe disorder.

Original languageEnglish (US)
Pages (from-to)18-21
Number of pages4
JournalJournal of Clinical Psychiatry
Volume65
Issue numberSUPPL. 14
StatePublished - Dec 1 2004
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Zohar, J., Kennedy, J. L., Hollander, E., & Koran, L. M. (2004). Serotonin-1D hypothesis of obsessive-compulsive disorder: An update. Journal of Clinical Psychiatry, 65(SUPPL. 14), 18-21.